NEWS
Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually
Cosmos Health's subsidiary, Cana Laboratories, has signed a contract manufacturing agreement with Australian wellness company Humacology. The agreement entails producing up to 500,000 units of CBD products annually. This is the second major deal for Cana in a week, following a similar agreement with Provident Pharmaceuticals for 4.32 million units of DE3-SOLE. Humacology, known for high-quality CBD therapies and medicinal cannabis, is expanding globally and has chosen Cana for its manufacturing needs. CEO of Cosmos, Greg Siokas, highlighted the company's rapid growth in high-margin contract manufacturing and hinted at more upcoming agreements.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1066Followers
68Following
7341Visitors
Follow